Genetic Programs Between Steroid-Sensitive and Steroid-Insensitive Interstitial Lung Disease

Area of Science:

• Pulmonary Medicine
• Genomics
• Bioinformatics

Background:

• Corticosteroid (GC) effectiveness significantly varies across interstitial lung diseases (ILDs).
• Understanding the molecular basis of GC sensitivity is crucial for tailoring treatments.
• Idiopathic pulmonary fibrosis (IPF), cryptogenic organizing pneumonia (COP), and non-specific interstitial pneumonia (NSIP) represent distinct ILD subtypes with differing prognoses.

Purpose of the Study:

• To compare gene expression profiles in COP, IPF, and NSIP patients.
• To identify molecular players and pathways associated with GC sensitivity in ILDs.
• To elucidate the role of inflammatory responses in ILD pathogenesis and GC response.

Main Methods:

• Analysis of three public gene expression datasets (GSE21411, GSE47460, GSE32537).
• Identification of differentially expressed genes (DEGs) between ILD subtypes and healthy controls.
• Functional enrichment analysis and protein-protein interaction network analysis.

Main Results:

• Significant DEGs were identified across ILD groups, primarily enriched in inflammatory response pathways.
• The interleukin-17 (IL-17) and tumor necrosis factor (TNF) signaling pathways were implicated in ILDs.
• Ten hub genes related to inflammation showed higher expression in IPF than COP.
• FOSL1 and DDIT4 were identified as key genes related to GC response.

Conclusions:

• The inflammatory response is a critical factor in ILD progression.
• Inflammatory reactions are more pronounced in IPF compared to COP.
• FOSL1 and DDIT4 represent potential therapeutic targets for modulating GC response in ILDs.